NASDAQ:RVPH
Reviva Pharmaceuticals Holdings, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
revivapharma.comipo date
Oct 18, 2018
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus